Introduction
▼ Every minute a woman dies during labour or delivery. The main cause of maternal mortality is post partum haemorrhage (PPH) (24 %) [ 1 ] . 99 % of mortality occurs in developing nations and is due to the lack of proper resources [ 2 ] . After vaginal delivery fi rst line of therapy for hemorrhage is bimanual compression of the uterus until stabilization is achieved. Often this cannot be maintained by an individual for more than 150 s and a paired team may not last for more than 5 min [ 3 ] . Uterine balloon tamponade has been found to be eff ective even in resource-poor settings but its implementation and use in these settings is diffi cult [ 4 ] . Furthermore, intrauterine tamponade may stop acute haemorrhage but may interfere with physiological contraction of the myometrium. In addition, uterine atony may develop Fig. 1 ). A bandage is fi xed like a very tight belt preventing the uterus from rising and a roll of pads compresses the uterus from the fundus ( • ▶ Fig. 2 ).
Counterpressure is achieved by a second bandage from the anterior to the posterior part of the belt pressing the pads inside the vagina fi rmly against the uterus ( • ▶ Fig. 2 ). The hip areas are padded to reduce skin trauma.
Results

▼
Since 1997 sumo compression has been used sporadically in the department of obstetrics and gynaecology, Klinikum Fulda, Germany. Between December 2010 and October 2012 fi ve patients (24-34 years) gravida 1, parity 0 were treated. The gestational age at delivery was 34 + 1 to 41 + 4 weeks of pregnancy. There were no signs of venous stasis in the legs. Pedal pulses remained palpable indicating that the aorta is not signifi cantly altered by the sumo-compression. In all patients up to 9 (3-9) units of blood and 8 (0-8) units of fresh frozen plasma had been transfused during the procedure and on the intensive care unit. Once fi brinogen resp. tranexamic acid was given the patients were kept in the intensive care unit for 1-2 days and general anaesthesia lasted 4-20 h. "Sumo-compression" was removed before anaesthesia was stopped. Hospital stay was between 4-12 days. One woman complained of a little hip pain lasting some days. Another woman showed a skin abrasion in the same area.
Discussion
▼
The "sumo-compression" technique is safe and easy to administer. Laparotomy pads and elastic bandages are available even in resource-poor settings. Uterovaginal packing is known since a long time (see method of Bumm cited in [ 5 ] ) and has been successfully used in a great number of patients [ 6 ] . Diff erently from conventional balloon tamponage and intrauterine packing "sumo-compression" does not interfere with normal contraction of the uterus during recovery and may avoid further complications like secondary PPH or infection. Profi ting by the same general anaesthesia "Sumo-compression" should be utilized after the use of contractile drugs, curettage and surgical intervention as described above had been unsuccessful.
In extreme obstetrical situations such as PPH the name of an eff ective method should be easy to remember and at the same time be illustrative such as "sumo-compression" or "quilting sutures". To stop PPH after caesarean delivery we use "quilting sutures", 6-10 U-stitches from the fundus to the cervix. They are easy to perform and eff ective in stopping haemorrhage by compressing the uterus [ 7 ] . In case of PPH after C-section "quilting sutures" in a second laparotomy may be more eff ective than "sumo-compression". With both methods in our department post partum hysterectomy could nearly always be avoided. The ease of the method encourages the obstetrician to act without loosing valuable time by hesitating to perform one of the more complicated procedures. Hopefully the "sumo-compression" will help to reduce maternal morbidity and mortality particularly in resource-poor settings. It is important not to delay in performing "sumo-compression" in order to alter the clotting system as less as possible.
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